Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-061032
Filing Date
2022-12-13
Accepted
2022-12-13 18:07:37
Documents
2
Period of Report
2022-12-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5683
2 POA DOCUMENT poa.txt EX-24 3050
  Complete submission text file 0001209191-22-061032.txt   10151
Mailing Address C/O LUMENA PHARMACEUTICALS, INC. 12531 HIGH BLUFF DRIVE, SUITE 110 SAN DIEGO CA 92130
Business Address
Dorenbaum Alejandro (Reporting) CIK: 0001606083 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40315 | Film No.: 221460704

Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Issuer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations